BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asokan R, Banda NK, Szakonyi G, Chen XS, Holers VM. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE). Mol Immunol 2013;53:99-110. [PMID: 22885687 DOI: 10.1016/j.molimm.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Herbáth M, Szekeres Z, Kövesdi D, Papp K, Erdei A, Prechl J. Coadministration of antigen-conjugated and free CpG: effects of in vitro and in vivo interactions in a murine model. Immunol Lett 2014;160:178-85. [PMID: 24565977 DOI: 10.1016/j.imlet.2014.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
2 Dewangan HK, Pandey T, Singh S. Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model. Artif Cells Nanomed Biotechnol 2018;46:2033-42. [PMID: 29179600 DOI: 10.1080/21691401.2017.1408118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Kremlitzka M, Mácsik-Valent B, Erdei A. Syk is indispensable for CpG-induced activation and differentiation of human B cells. Cell Mol Life Sci 2015;72:2223-36. [PMID: 25543269 DOI: 10.1007/s00018-014-1806-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
4 Henriques A, Silva I, Inês L, Souto-carneiro MM, Pais ML, Trindade H, da Silva JAP, Paiva A. CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus. Clin Exp Med 2016;16:227-32. [DOI: 10.1007/s10238-015-0348-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
5 Gautam I, Storad Z, Filipiak L, Huss C, Meikle CK, Worth RG, Wuescher LM. From Classical to Unconventional: The Immune Receptors Facilitating Platelet Responses to Infection and Inflammation. Biology (Basel) 2020;9:E343. [PMID: 33092021 DOI: 10.3390/biology9100343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Vandendriessche S, Cambier S, Proost P, Marques PE. Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis. Front Cell Dev Biol 2021;9:624025. [PMID: 33644062 DOI: 10.3389/fcell.2021.624025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Feng Y, Yang M, Wu H, Lu Q. The pathological role of B cells in systemic lupus erythematosus: From basic research to clinical. Autoimmunity 2020;53:56-64. [PMID: 31876195 DOI: 10.1080/08916934.2019.1700232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Teirilä L, Heikkinen-Eloranta J, Kotimaa J, Meri S, Lokki AI. Regulation of the complement system and immunological tolerance in pregnancy. Semin Immunol 2019;45:101337. [PMID: 31757607 DOI: 10.1016/j.smim.2019.101337] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
9 Miles K, Simpson J, Brown S, Cowan G, Gray D, Gray M. Immune Tolerance to Apoptotic Self Is Mediated Primarily by Regulatory B1a Cells. Front Immunol 2017;8:1952. [PMID: 29403471 DOI: 10.3389/fimmu.2017.01952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
10 Leffler J, Bengtsson AA, Blom AM. The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis 2014;73:1601-6. [PMID: 24845390 DOI: 10.1136/annrheumdis-2014-205287] [Cited by in Crossref: 138] [Cited by in F6Publishing: 124] [Article Influence: 17.3] [Reference Citation Analysis]
11 Costa-Reis P, Sullivan KE. Genetics and epigenetics of systemic lupus erythematosus. Curr Rheumatol Rep 2013;15:369. [PMID: 23943494 DOI: 10.1007/s11926-013-0369-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
12 Herrero R, Real LM, Rivero-Juárez A, Pineda JA, Camacho Á, Macías J, Laplana M, Konieczny P, Márquez FJ, Souto JC, Soria JM, Saulle I, Lo Caputo S, Biasin M, Rivero A, Fibla J, Caruz A. Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection. Genes Immun 2015;16:134-41. [PMID: 25569262 DOI: 10.1038/gene.2014.71] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
13 Gies V, Schickel JN, Jung S, Joublin A, Glauzy S, Knapp AM, Soley A, Poindron V, Guffroy A, Choi JY, Gottenberg JE, Anolik JH, Martin T, Soulas-Sprauel P, Meffre E, Korganow AS. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. JCI Insight 2018;3:96795. [PMID: 29515028 DOI: 10.1172/jci.insight.96795] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
14 Birmingham DJ, Hebert LA. The Complement System in Lupus Nephritis. Seminars in Nephrology 2015;35:444-54. [DOI: 10.1016/j.semnephrol.2015.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
15 Sousa H, Bastos MJ, Ribeiro J, Oliveira S, Breda E, Catarino R, Medeiros R. 5'UTR +24T>C CR2 is not associated with nasopharyngeal carcinoma development in the North Region of Portugal. Oral Dis 2016;22:280-4. [PMID: 26748973 DOI: 10.1111/odi.12436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Erdei A, Kovács KG, Nagy-Baló Z, Lukácsi S, Mácsik-Valent B, Kurucz I, Bajtay Z. New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4. Immunol Lett 2021;237:42-57. [PMID: 34186155 DOI: 10.1016/j.imlet.2021.06.006] [Reference Citation Analysis]
17 Atkinson JP, Yu CY. The Complement System in Systemic Lupus Erythematosus. Systemic Lupus Erythematosus. Elsevier; 2016. pp. 81-112. [DOI: 10.1016/b978-0-12-801917-7.00012-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kovács KG, Mácsik-Valent B, Matkó J, Bajtay Z, Erdei A. Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells. Front Immunol 2021;12:620427. [PMID: 33868238 DOI: 10.3389/fimmu.2021.620427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zheng Y, Zheng Z, Zhang K, Zhu P. Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management. Autoimmun Rev 2021;:102992. [PMID: 34793961 DOI: 10.1016/j.autrev.2021.102992] [Reference Citation Analysis]
20 Herbáth M, Papp K, Erdei A, Prechl J. Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching. J Immunol Res 2015;2015:340468. [PMID: 26380319 DOI: 10.1155/2015/340468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]